Back to results
US 2011/0086039 A1Published application
Methods of Treating Liver Fibrosis and Pre-Cirrhosis with Epidermal Growth Factor Receptor Inhibitors
AssigneeThe General Hospital Corporation
InventorsKenneth Tanabe, Bryan C. Fuchs
Life of this patent
Estimating the term…
Abstract
This invention relates generally to a therapeutic use of epidermal growth factor receptor inhibitors to reduce fibrosis, e.g., liver fibrosis, or pre-cirrhosis in a subject.
Claims17
A method of reducing fibrosis or pre-cirrhosis in a subject, the method comprising:
- selecting a subject on the basis that they have, or are at risk of developing, fibrosis or pre-cirrhosis;
- administering to the subject a therapeutically effective amount of an epidermal growth factor receptor (EGFR) inhibitor;
- and
- detecting an effect of EGFR inhibition on liver fibrosis or pre-cirrhosis in the subject, thereby reducing fibrosis or pre-cirrhosis in the subject.
1 more element
Dependencies are inferred from the claim text.